2005
DOI: 10.1016/j.ejphar.2005.02.007
|View full text |Cite
|
Sign up to set email alerts
|

The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 44 publications
0
34
0
Order By: Relevance
“…All of 50 representative control animals and 69 of 84 animals undergoing any of the interventions described above had augmented breaths during the citric acid challenge. The majority (Ͼ80%) of animals studied produced multiple (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14) augmented breaths during the citric acid challenges. Severing either the RLNs or SLNs, or TTX pretreatment decreased the number of augmented breaths induced by citric acid challenge (8 of the 11 animals in these treatment groups sighed Յ1 time and six of these eleven did not sigh at all during the citric acid challenges).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…All of 50 representative control animals and 69 of 84 animals undergoing any of the interventions described above had augmented breaths during the citric acid challenge. The majority (Ͼ80%) of animals studied produced multiple (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14) augmented breaths during the citric acid challenges. Severing either the RLNs or SLNs, or TTX pretreatment decreased the number of augmented breaths induced by citric acid challenge (8 of the 11 animals in these treatment groups sighed Յ1 time and six of these eleven did not sigh at all during the citric acid challenges).…”
Section: Resultsmentioning
confidence: 99%
“…Not surprisingly, therefore, citric acid-induced coughing was unaffected by pretreatment with atropine, the ␤-agonists albuterol and isoproterenol, the cyclooxygenase inhibitor indomethacin, the bradykinin B2 receptor antagonist FR-173657, the combination of pyrilamine and ICI-198615 (histamine and cysteinyl-leukotriene receptor antagonists, respectively), or depletion of extracellular Ca 2ϩ . This reveals an additional distinction between airway C fibers and the cough receptors, because airway C fibers can be directly activated by some autacoids [e.g., 5-HT, adenosine, bradykinin, ATP, anandamide, 15-HETE (23,25,37,56)] and sensitized by others [e.g., bradykinin, histamine, PGE2, adrenaline (8,13,17,19,30,36)]. Rather, the effects of acid on the cough receptors appeared to be direct.…”
Section: Fig 7 Lowering the CLmentioning
confidence: 99%
“…Indeed, it was postulated that elevated SP in nasal secretions defines a distinct population of patients with chronic cough, those with "upper airway cough syndrome" (Lim et al, 2011). The interpretation of these observations is, however, not straightforward since inhaled SP does not provoke cough in the guinea pig (El-Hashim and Amine, 2005), nor do tachykinin NK1R (the receptor SP) antagonists relieve spontaneous coughing in men (Joos et al, 1996). Thus far, elevated SP appears to be marker of overactive sensory nerves in the respiratory tract, rather than a diseasecausing substance.…”
Section: B Transient Receptor Potential Channels Inmentioning
confidence: 97%
“…The sensitization of cough apparent when comparing the responses to bradykininevoked cough with or without preceding subthreshold challenge doses has not been previously described. However, a sensitizing effect of subthreshold doses of bradykinin on subsequently evoked cough responses has been noted (Fox et al, 1996;El-Hashim and Amine, 2005;Mazzone et al, 2005). These sensitizing effects may be both central nervous system and NK 1 receptor dependent (Joad et al, 2004;Mazzone et al, 2005;Canning and Mori, 2011;Cinelli et al, 2015) or could depend on local actions of eicosanoids released from structural cells following bradykinin B 2 receptor activation (Salari and Chan-Yeung, 1989;Arakawa et al, 1992;Gatti et al, 2006;Petho and Reeh, 2012).…”
Section: Treatmentmentioning
confidence: 99%